Forty-three years after it was founded, with billions of dollars invested, the global biotech industry is still not positioned as a mature low-risk sector for the international investor com-munity. Despite the clear commercial success of a number of leading companies and overall growth of the industry’s rev-enues, most biotech companies are not profi table and many fail to overcome the formidable barrier constituted by the high cost of the sector’s research and development.
However, over the last four years, visible signs of change have appeared, which could be harbingers of an approaching turning point in this trend.This article analyzes the historic background of the biotech in-dustry’s business models and corporate structures, as well as their impact on the industry’s fi nancial framework.
It examines recent changes implemented by the sector’s main actors-in-cluding young startups, venture capital funds and big pharma companies-to mitigate fi nancial risk associated with develop-ment of new biotechnology products.Finally, it discusses the challenges and opportunities that these tendencies entail for Cuban biotechnology development and proposes adoption of business policies more tolerant of the fi nancial risk inherent in this sector, as a condition for at-tracting venture capital. KEYWORDS Biotechnology, fund raising, risk management, entrepreneurship, Cuba.
Mouse anti Human IgG1 |
10R-I110a |
Fitzgerald |
1 ml |
EUR 664.8 |
Description: Mouse anti Human IgG1 antibody |
Mouse anti Human IgG1 |
10R-I127a |
Fitzgerald |
1 mg |
EUR 586.8 |
Description: Mouse anti Human IgG1 antibody |
Mouse anti Human IgG1 (HRP) |
43-1003 |
Fitzgerald |
1 ml |
EUR 376.8 |
Description: Mouse Anti-Human IgG1, Fc-HRP |
anti-RhoD human antigen IgG1 |
131-A-01mg |
Virogen |
0,1 mg |
EUR 321 |
|
Description: anti-RhoD human antigen IgG1 |
anti-RhoD human antigen IgG1 |
131-A-1000ug |
Virogen |
1000 ug |
EUR 1539 |
|
Description: anti-RhoD human antigen IgG1 |
anti-RhoD human antigen IgG1 |
131-A |
Virogen |
1 MG |
EUR 850 |
anti-RhoD human antigen IgG1 |
131-A-100ugvial |
Virogen |
100ug/vial |
EUR 150 |
|
Description: anti-RhoD human antigen IgG1 |
HRP*Monoclonal Mouse Anti- Human IgG1 |
C030248-10ml |
Unibiotest |
10ml |
EUR 3162 |
HRP*Monoclonal Mouse Anti- Human IgG1 |
C030248-1ml |
Unibiotest |
1ml |
EUR 525.6 |
Human IC IgG1/IgG1 antibodies combination |
ICIGG1FPE-50T |
ImmunoStep |
50 test |
EUR 165 |
FITC*Monoclonal Mouse Anti- Human IgG1 |
C030648-10ml |
Unibiotest |
10ml |
EUR 3162 |
FITC*Monoclonal Mouse Anti- Human IgG1 |
C030648-1ml |
Unibiotest |
1ml |
EUR 525.6 |
BIOTIN*Monoclonal Mouse Anti- Human IgG1 |
C030848-10ml |
Unibiotest |
10ml |
EUR 2148 |
BIOTIN*Monoclonal Mouse Anti- Human IgG1 |
C030848-1ml |
Unibiotest |
1ml |
EUR 424.8 |
Anti-OX40L (Oxelumab), Human IgG1 Antibody |
A1088-200 |
Biovision |
each |
EUR 874.8 |
Anti-EGFR (Matuzumab), Human IgG1 Antibody |
A1090-200 |
Biovision |
each |
EUR 874.8 |
Anti-RSV (Felvizumab), Human IgG1 Antibody |
A1446-200 |
Biovision |
each |
EUR 874.8 |
Anti-CD20 (Ofatumumab), Human IgG1 Antibody |
A2172-100 |
Biovision |
100 µg |
EUR 564 |
Anti-CD11a (Efalizumab), Human IgG1 Antibody |
A1089-200 |
Biovision |
each |
EUR 874.8 |
Anti-CD40L (Ruplizumab), Human IgG1 Antibody |
A1094-200 |
Biovision |
each |
EUR 874.8 |
Anti-CD22 (Epratuzumab), Human IgG1 Antibody |
A1445-200 |
Biovision |
each |
EUR 933.6 |
Anti-CD38 (Daratumumab), Human IgG1 Antibody |
A2151-100 |
Biovision |
100 µg |
EUR 612 |
Anti-PCSK9 (Alirocumab), Human IgG1 Antibody |
A2153-100 |
Biovision |
100 µg |
EUR 612 |
Anti-TNSF13B (Belimumab), Human IgG1 Antibody |
A2170-100 |
Biovision |
100 µg |
EUR 612 |
Anti-VEGFR2 (Ramucirumab), Human IgG1 Antibody |
A2139-100 |
Biovision |
100 µg |
EUR 612 |
Anti-Beta-galactosidase, Human IgG1 Antibody |
A1104-200 |
Biovision |
each |
EUR 933.6 |
Anti-Human IgG1:HRP |
IM151 |
Cygnus Technologies |
1 ml |
EUR 386.4 |
|
Description: Anti-Human IgG1:HRP by Cygnus Technologies is available in Europe via Gentaur. |
Anti-human IgG1 antibody |
STJ15100186 |
St John's Laboratory |
250 µg |
EUR 403.2 |
Description: This monoclonal antibody enables sensitive and specific detection of human IgG1 in e.g. antigen-specific ELISA. |
Anti-human IgG1 antibody |
STJ15100187 |
St John's Laboratory |
250 µg |
EUR 440.4 |
Description: This monoclonal antibody enables sensitive and specific detection of human IgG1 in e.g. antigen-specific ELISA. |
Human IgG1 Antibody |
R20187-100UG |
NSJ Bioreagents |
100ug |
EUR 347.65 |
Description: This recombinant Human IgG1 antibody reacts to the heavy chain of hIgG1. No cross reactivity with IgG2, IgG3, IgG4, IgM, IgA, IgD, IgE, mouse/rat/goat IgG. |
Human IgG1 Antibody |
R20187BTN-50UG |
NSJ Bioreagents |
50ug |
EUR 347.65 |
Description: This recombinant Human IgG1 antibody reacts to the heavy chain of human IgG1. No cross reactivity with human IgG2, IgG3, IgG4, IgM, IgA, IgD, IgE, mouse/rat/goat IgG. |
Human IgG1 Antibody |
R20187SAF-250UG |
NSJ Bioreagents |
250ug |
EUR 832.15 |
Description: This recombinant Human IgG1 antibody reacts to the heavy chain of hIgG1. No cross reactivity with IgG2, IgG3, IgG4, IgM, IgA, IgD, IgE, mouse/rat/goat IgG. |
Anti-V5 epitope tag, Human IgG1 Antibody |
A1103-200 |
Biovision |
each |
EUR 933.6 |
Human IgG1 Anti-Zika Virus NS1 Antibody |
MAB12122-100 |
The Native Antigen Company |
0.1 |
EUR 459.27 |
|
Description: Human IgG monoclonal antibody specific for Zika virus NS1 (clone B4) |
Human IgG1 Anti-Zika Virus NS1 Antibody |
MAB12122-250 |
The Native Antigen Company |
0.25 |
EUR 890.47 |
|
Description: Human IgG monoclonal antibody specific for Zika virus NS1 (clone B4) |
Human IgG1 Anti-Zika Virus NS1 Antibody |
MAB12122-500 |
The Native Antigen Company |
0.5 |
EUR 1222.17 |
|
Description: Human IgG monoclonal antibody specific for Zika virus NS1 (clone B4) |
Anti-PD-L1 (Avelumab), Human IgG1 Antibody |
A2152-100 |
Biovision |
100 µg |
EUR 612 |
Anti-CD52 (Campath-1H), Human IgG1 Antibody |
A1105-200 |
Biovision |
each |
EUR 933.6 |
Anti-TNF-α (Golimumab), Human IgG1 Antibody |
A2141-100 |
Biovision |
100 µg |
EUR 612 |
Anti-PD-L1 (Durvalumab), Human IgG1 Antibody |
A2109-100 |
Biovision |
100 µg |
EUR 612 |
Anti-IL-1β (Canakinumab), Human IgG1 Antibody |
A2144-100 |
Biovision |
100 µg |
EUR 564 |
Anti-IL-23α (Guselkumab), Human IgG1 Antibody |
A2147-100 |
Biovision |
100 µg |
EUR 612 |
Anti-TNF alpha (Infliximab), Human IgG1 Antibody |
A1097-200 |
Biovision |
each |
EUR 933.6 |
Anti-IL-12β (Ustekinumab), Human IgG1 Antibody |
A2137-100 |
Biovision |
100 µg |
EUR 612 |
Anti-IL-17α (Secukinumab), Human IgG1 Antibody |
A2154-100 |
Biovision |
100 µg |
EUR 612 |
Anti-Flavivirus group antigen, Human IgG1 Antibody |
A1102-200 |
Biovision |
each |
EUR 933.6 |
Anti-CD80 (Galiximab), Human IgG1, lambda Antibody |
A2011-200 |
Biovision |
200 µg |
EUR 818.4 |
Anti-IGF-1R (Teprotumumab), Human IgG1 Antibody |
A2160-100 |
Biovision |
100 µg |
EUR 612 |
Monoclonal Anti-IFNγ Antibody, Human IgG1 (8C5F8) |
IFN-M412 |
ACROBIOSYSTEMS |
100ug |
EUR 2354 |
|
Description: IFNγ is secreted by innate-like lymphocytes, including group 1 innate lymphoid cells (ILC1s), and by adaptive lymphocytes, including T helper 1 (TH1) cells and cytotoxic T lymphocytes (CTLs), in response to cytokine and antigen stimulation. It plays important roles in tissue homeostasis, immune and inflammatory responses and tumour immunosurveillance. Anti-IFNγ antibody, is a monoclonal antibody used to detected IFNγ, which is a recombinant IgG1 kappa, humanized monoclonal antibody that selectively binds with Human IFN-gamma protein. |
Monoclonal Anti-IFNγ Antibody, Human IgG1 (13E6H4) |
IFN-M411 |
ACROBIOSYSTEMS |
100ug |
EUR 2354 |
|
Description: IFNγ is secreted by innate-like lymphocytes, including group 1 innate lymphoid cells (ILC1s), and by adaptive lymphocytes, including T helper 1 (TH1) cells and cytotoxic T lymphocytes (CTLs), in response to cytokine and antigen stimulation. It plays important roles in tissue homeostasis, immune and inflammatory responses and tumour immunosurveillance. Anti-IFNγ antibody, is a monoclonal antibody used to detected IFNγ, which is a recombinant IgG1 kappa, humanized monoclonal antibody that selectively binds with Human IFN-gamma protein. |
Monoclonal Anti-IFNγ Antibody, Human IgG1 (13E6H6) |
IFN-M414 |
ACROBIOSYSTEMS |
100ug |
EUR 2354 |
|
Description: IFNγ is secreted by innate-like lymphocytes, including group 1 innate lymphoid cells (ILC1s), and by adaptive lymphocytes, including T helper 1 (TH1) cells and cytotoxic T lymphocytes (CTLs), in response to cytokine and antigen stimulation. It plays important roles in tissue homeostasis, immune and inflammatory responses and tumour immunosurveillance. Anti-IFNγ antibody, is a monoclonal antibody used to detected IFNγ, which is a recombinant IgG1 kappa, humanized monoclonal antibody that selectively binds with Human IFN-gamma protein. |
Goat Anti-Mouse IgG1, Human ads-HRP |
LF-SA8005H |
Abfrontier |
1.0 ml |
Ask for price |
Description: Goat polyclonal to mouse IgG1 |
Anti-CCR4 (Mogamulizumab), Human IgG1, kappa Antibody |
A2005-200 |
Biovision |
200 µg |
EUR 818.4 |
Human IgG1 |
31R-1087 |
Fitzgerald |
1 mg |
EUR 333.6 |
Description: Purified native Human IgG1 protein |
Anti-Carcinoembryonic antigen (Arcitumomab), Human IgG1 Antibody |
A1096-200 |
Biovision |
each |
EUR 874.8 |
Mouse anti-Human IgG1 Antibody |
abx401124-05mg |
Abbexa |
0.5 mg |
EUR 794.4 |
|
Sheep anti-Human IgG1 Antibody |
abx401125-05mg |
Abbexa |
0.5 mg |
EUR 1128 |
|
Mouse Anti-Human IgG1 antibody |
STJ99560-100l |
St John's Laboratory |
100 µl |
EUR 214.8 |
Description: Unconjugated Mouse monoclonal to Human IgG1 antibody |
Mouse Anti-Human IgG1 antibody |
STJ99560-1mL |
St John's Laboratory |
1 mL |
EUR 1438.8 |
Description: Unconjugated Mouse monoclonal to Human IgG1 antibody |
Anti-IL-2R alpha (Daclizumab), Human IgG1 Antibody |
A1099-200 |
Biovision |
each |
EUR 874.8 |
Anti-IL-6 receptor (Tocilizumab), Human IgG1 Antibody |
A1447-200 |
Biovision |
each |
EUR 933.6 |
Monoclonal Anti-TNF-alpha Antibody, Human IgG1 (13B8) |
TNA-AM493 |
ACROBIOSYSTEMS |
1mg |
EUR 321 |
|
Description: Tumor necrosis factor alpha (TNFα) is a cytokine produced primarily by monocytes and macrophages. It is found in synovial cells and macrophages in the tissues.The primary role of TNFα is in the regulation of immune cells. TNFα is able to induce apoptotic cell death, to induce inflammation, and to inhibit tumorigenesis and viral replication. Dysregulation of TNFα production has been implicated in a variety of human diseases, including major depression, Alzheimers disease and cancer. Recombinant TNFα is used as an immunostimulant under the INN tasonermin. TNFα can be produced ectopically in the setting of malignancy and parallels parathyroid hormone both in causing secondary hypercalcemia and in the cancers with which excessive production is associated. |
Monoclonal Anti-TNF-alpha Antibody, Human IgG1 (16H5) |
TNA-AM494 |
ACROBIOSYSTEMS |
100ug |
EUR 2140 |
|
Description: Tumor necrosis factor alpha (TNFα) is a cytokine produced primarily by monocytes and macrophages. It is found in synovial cells and macrophages in the tissues.The primary role of TNFα is in the regulation of immune cells. TNFα is able to induce apoptotic cell death, to induce inflammation, and to inhibit tumorigenesis and viral replication. Dysregulation of TNFα production has been implicated in a variety of human diseases, including major depression, Alzheimers disease and cancer. Recombinant TNFα is used as an immunostimulant under the INN tasonermin. TNFα can be produced ectopically in the setting of malignancy and parallels parathyroid hormone both in causing secondary hypercalcemia and in the cancers with which excessive production is associated. |
Anti-Nectin-4 (Enfortumab Vedotin), Human IgG1 Antibody |
A2176-100 |
Biovision |
100 µg |
EUR 612 |
Monoclonal Mouse Anti-Human IgG1 |
C010215-10mg |
Unibiotest |
10mg |
EUR 2655.6 |
Monoclonal Mouse Anti-Human IgG1 |
C010215-1mg |
Unibiotest |
1mg |
EUR 525.6 |
Monoclonal Anti-Monkeypox-H3L Antibody, Human IgG1 (1C5) |
H3L-M611 |
ACROBIOSYSTEMS |
1mg |
EUR 374.5 |
|
Description: Monkeypox is a rare zoonosis caused by monkeypox virus, which has become the most serious orthpoxvirus and consists of complex double stranded DNA. The cases are mostly in central and western Africa. The pathogenesis of monkeypox is that the virus invades the body from respiratory mucosa , multiplies in lymphocytes, and incurs into blood producing transient venereal toxemia. after the virus multiplies in cells, the cells can invade the blood and propagate to the skin of the whole body, causing lesions. E8L can Binds to chondroitin sulfate on the cell surface to provide virion attachment to target cell. |
Human IgG1 Anti-Flavivirus Envelope Protein Antibody (4G2) |
MAB12268-100 |
The Native Antigen Company |
0.1 |
EUR 290.87 |
|
Description: Human IgG1 monoclonal antibody specific for flavivirus envelope protein (clone 4G2) |
Human IgG1 Anti-Flavivirus Envelope Protein Antibody (4G2) |
MAB12268-500 |
The Native Antigen Company |
0.5 |
EUR 1236.2 |
|
Description: Human IgG1 monoclonal antibody specific for flavivirus envelope protein (clone 4G2) |
Monoclonal Anti-Monkeypox-L1R Antibody, Human IgG1 (10D8) |
L1R-M663 |
ACROBIOSYSTEMS |
100ug |
EUR 2493.1 |
|
Description: Monkeypox is a rare zoonosis caused by monkeypox virus, which has become the most serious orthpoxvirus and consists of complex double stranded DNA. The cases are mostly in central and western Africa. The pathogenesis of monkeypox is that the virus invades the body from respiratory mucosa, multiplies in lymphocytes, and incurs into blood producing transient venereal toxemia. after the virus multiplies in cells, the cells can invade the blood and propagate to the skin of the whole body, causing lesions. |
Mouse Anti Human Igg1 (Fc) (Ch2 Domain) Monoclonal Antibody |
CABT-48866MH |
Creative Diagnostics |
0.2 mg |
EUR 920.4 |
Human IgG1 protein |
31-AI17 |
Fitzgerald |
1 mg |
EUR 163.2 |
Description: Purified Human IgG1 protein |
human IgG1 control |
E4A11C03 |
EnoGene |
50ug |
EUR 255 |
Description: Available in various conjugation types. |
Human IgG1 Control |
TP1357-10mg |
TargetMol Chemicals |
10mg |
Ask for price |
|
Description: Human IgG1 Control |
Human IgG1 Control |
TP1357-1g |
TargetMol Chemicals |
1g |
Ask for price |
|
Description: Human IgG1 Control |
Human IgG1 Control |
TP1357-1mg |
TargetMol Chemicals |
1mg |
Ask for price |
|
Description: Human IgG1 Control |
Human IgG1 Control |
TP1357-50mg |
TargetMol Chemicals |
50mg |
Ask for price |
|
Description: Human IgG1 Control |
Human IgG1 Control |
TP1357-5mg |
TargetMol Chemicals |
5mg |
Ask for price |
|
Description: Human IgG1 Control |
Purified human IgG1 |
E16FHCU001-500U |
EnoGene |
0.5 mg |
EUR 433.33 |
Description: Available in various conjugation types. |
anti-FAS IgG1 mAb |
019-A-01mg |
Virogen |
0,1 mg |
EUR 321 |
|
Description: anti-FAS IgG1 (monoclonal) Produced against a recombinant protein. |
anti-FAS IgG1 mAb |
019-A-1000ug |
Virogen |
1000 ug |
EUR 1539 |
|
Description: anti-FAS IgG1 (monoclonal) Produced against a recombinant protein. |
anti-TGE IgG1 mAb |
028-A-01mg |
Virogen |
0,1 mg |
EUR 321 |
|
Description: anti-TGE IgG1 (monoclonal) Produced against purified TGE virus 1E11. |
anti-TGE IgG1 mAb |
028-A-1000ug |
Virogen |
1000 ug |
EUR 1539 |
|
Description: anti-TGE IgG1 (monoclonal) Produced against purified TGE virus 1E11. |
anti-FAS IgG1 mAb |
029-A-01mg |
Virogen |
0,1 mg |
EUR 321 |
|
Description: anti-FAS IgG1 (monoclonal) Produced against a recombinant protein. |
anti-FAS IgG1 mAb |
029-A-1000ug |
Virogen |
1000 ug |
EUR 1539 |
|
Description: anti-FAS IgG1 (monoclonal) Produced against a recombinant protein. |
anti-FAS IgG1 mAb |
039-A-01mg |
Virogen |
0,1 mg |
EUR 321 |
|
Description: anti-FAS IgG1 (monoclonal) Produced against a recombinant protein. |
anti-FAS IgG1 mAb |
039-A-1000ug |
Virogen |
1000 ug |
EUR 1539 |
|
Description: anti-FAS IgG1 (monoclonal) Produced against a recombinant protein. |
Rat anti Mouse IgG1 |
41R-1114 |
Fitzgerald |
100 ug |
EUR 318 |
Description: Rat anti Mouse IgG1 secondary antibody |
Mouse anti Rat IgG1 |
41R-1117 |
Fitzgerald |
100 ug |
EUR 318 |
Description: Mouse anti Rat IgG1 secondary antibody |
APC anti-rat IgG1 |
E16SHA505-025U |
EnoGene |
25 μg |
EUR 325 |
Description: Available in various conjugation types. |
APC anti-rat IgG1 |
E16SHA505-100U |
EnoGene |
100 μg |
EUR 736.67 |
Description: Available in various conjugation types. |
Anti-IL-2R alpha (CD25) (Basiliximab), Human IgG1 Antibody |
A1098-200 |
Biovision |
each |
EUR 874.8 |
anti-HCV core IgG1 |
0116-A-01mg |
Virogen |
0,1 mg |
EUR 321 |
|
Description: anti-HCV core IgG1 (monoclonal) Produced against a recombinant, HCV core 00115-V, protein. |
anti-HCV core IgG1 |
0116-A-1000ug |
Virogen |
1000 ug |
EUR 1539 |
|
Description: anti-HCV core IgG1 (monoclonal) Produced against a recombinant, HCV core 00115-V, protein. |
Goat anti Mouse IgG1 |
20R-IG003 |
Fitzgerald |
1 mg |
EUR 262.8 |
Description: Goat anti Mouse IgG1 antibody |
Goat anti Mouse IgG1 |
FNSA-0086 |
FN Test |
500 uL |
EUR 367.92 |
|
Description: Goat anti Mouse IgG1 secondary antibody |
FITC anti-rat IgG1 |
E16SHF505-050U |
EnoGene |
50 μg |
EUR 303.33 |
Description: Available in various conjugation types. |
FITC anti-rat IgG1 |
E16SHF505-500U |
EnoGene |
500 μg |
EUR 758.33 |
Description: Available in various conjugation types. |
PE anti-mouse IgG1 |
E16SHP501-050U |
EnoGene |
50 μg |
EUR 390 |
Description: Available in various conjugation types. |
PE anti-mouse IgG1 |
E16SHP501-200U |
EnoGene |
200 μg |
EUR 1148.33 |
Description: Available in various conjugation types. |
Monoclonal Anti-RSV-F0 broadly Antibody, Human IgG1 (3B4) |
RSV-M649 |
ACROBIOSYSTEMS |
100ug |
EUR 2493.1 |
|
Description: Human respiratory syncytial virus (HRSV) is the most common etiological agent of acute lower respiratory tract disease in infants and can cause repeated infections throughout life. The RSV fusion glycoprotein (RSV F) is the principal target of RSV neutralizing antibodies in human sera. The RSV F is a type I viral fusion protein synthesized as inactive, single-chain polypeptides that assemble into trimers. RSV F fuses the viral and host cell membranes by irreversible protein refolding from the labile prefusion conformation to the stable post-fusion conformation. |
APC anti-mouse IgG1 |
E16SHA501-050U |
EnoGene |
50 μg |
EUR 411.67 |
Description: Available in various conjugation types. |
APC anti-mouse IgG1 |
E16SHA501-200U |
EnoGene |
200 μg |
EUR 1191.67 |
Description: Available in various conjugation types. |
anti-mouse IgG1 mAb |
E4A03B11 |
EnoGene |
50ug |
EUR 255 |
Description: Available in various conjugation types. |
Anti-SARS-CoV-2 Nucleocapsid Antibody, Human IgG1 (AS41) |
NUN-S41 |
ACROBIOSYSTEMS |
100ug |
EUR 2974.6 |
|
Description: Anti-SARS-CoV-2 Nucleocapsid Antibody, Human IgG1 (AS41) (NUN-S41) is isolated from a SARS-CoV-2 infected patient and is recombinantly produced from human 293 cells (HEK293). As verified by binding test with N-NTD (Cat. No. NUN-C5143) and N-CTD (Cat. No. NUN-C5145) protein, this antibody can only bind to N-CTD (AA Ser 255 - Pro 364). ELISA test validated that this antibody can bind multiple N protein variants (Cat. No. NUN-C52H8, NUN-C52Hc, NUN-C52Hd, NUN-C52Hm) with similar affinity as compared to the wild type N protein (Cat. No. NUN-C5227). |
Sheep anti Bovine IgG1 |
20R-IS001 |
Fitzgerald |
1 mg |
EUR 289.2 |
Description: Sheep anti Bovine IgG1 antibody |
Rabbit anti Mouse IgG1 |
41C-CB5120 |
Fitzgerald |
1 mg |
EUR 373.2 |
Description: Rabbit anti Mouse IgG1 secondary antibody |
Sheep anti Bovine IgG1 |
41R-IS001 |
Fitzgerald |
1 mg |
EUR 289.2 |
Description: Affinity purified Sheep polyclonal Sheep anti Bovine IgG1 antibody |
Biotin anti-rat IgG1 |
E16SHB505-050U |
EnoGene |
50 μg |
EUR 303.33 |
Description: Available in various conjugation types. |
Biotin anti-rat IgG1 |
E16SHB505-500U |
EnoGene |
500 μg |
EUR 758.33 |
Description: Available in various conjugation types. |
FITC anti-mouse IgG1 |
E16SHF501-050U |
EnoGene |
50 μg |
EUR 303.33 |
Description: Available in various conjugation types. |
FITC anti-mouse IgG1 |
E16SHF501-500U |
EnoGene |
500 μg |
EUR 758.33 |
Description: Available in various conjugation types. |
Anti-EGFR domain III (Nimotuzumab), Human IgG1, kappa Antibody |
A2004-200 |
Biovision |
200 µg |
EUR 612 |
Human IgG1 Anti SARS-CoV-2 Nucleoprotein Antibody (CR3009) |
MAB12434-100 |
The Native Antigen Company |
0.1 |
EUR 555.66 |
Description: This is a recombinant monoclonal antibody for the detection of SARS-CoV-2 nucleoprotein. |
Human IgG1 Anti SARS-CoV-2 Nucleoprotein Antibody (CR3018) |
MAB12437-100 |
The Native Antigen Company |
0.1 |
EUR 489.89 |
Description: Recombinant monoclonal antibody . |
Human IgG1 Anti SARS-CoV-2 Nucleoprotein Antibody (CR3018) |
MAB12437-500 |
The Native Antigen Company |
0.5 |
EUR 1865.15 |
Description: Recombinant monoclonal antibody. |
Mouse Anti-Human IgG1 (Fc) Antibody |
abx023362-1mg |
Abbexa |
1 mg |
EUR 811.2 |
|
Mouse Anti-Human IgG1 (Fc) Antibody |
abx023375-05mg |
Abbexa |
0.5 mg |
EUR 1045.2 |
|
Mouse Anti-Human IgG1 antibody (AU) |
STJ99396-100l |
St John's Laboratory |
100 µl |
EUR 116.4 |
Description: AU conjugated Mouse monoclonal to Human IgG1 |
Mouse Anti-Human IgG1 antibody (AU) |
STJ99396-1mL |
St John's Laboratory |
1 mL |
EUR 560.4 |
Description: AU conjugated Mouse monoclonal to Human IgG1 |
HRP Rabbit anti-Human IgG1 (Fc) |
AS092 |
Abclonal |
100μL |
EUR 71.5 |
|
Mouse Anti-Human IgG1 antibody (HRP) |
STJ99546-100l |
St John's Laboratory |
100 µl |
EUR 116.4 |
Description: HRP conjugated Mouse monoclonal to Human IgG1 antibody |
Mouse Anti-Human IgG1 antibody (HRP) |
STJ99546-1mL |
St John's Laboratory |
1 mL |
EUR 560.4 |
Description: HRP conjugated Mouse monoclonal to Human IgG1 antibody |
Biotin anti-mouse IgG1 |
E16SHB501-050U |
EnoGene |
50 μg |
EUR 303.33 |
Description: Available in various conjugation types. |
Biotin anti-mouse IgG1 |
E16SHB501-500U |
EnoGene |
500 μg |
EUR 758.33 |
Description: Available in various conjugation types. |
Purified anti-rat IgG1 |
E16SHU505-500U |
EnoGene |
500 μg |
EUR 628.33 |
Description: Available in various conjugation types. |
Mouse Anti-Human IgG1 antibody (FITC) |
STJ99496-100l |
St John's Laboratory |
100 µl |
EUR 116.4 |
Description: FITC conjugated Mouse monoclonal to Human IgG1 |
Mouse Anti-Human IgG1 antibody (FITC) |
STJ99496-1mL |
St John's Laboratory |
1 mL |
EUR 560.4 |
Description: FITC conjugated Mouse monoclonal to Human IgG1 |
Human IgG1 Anti SARS-CoV-2 Spike (S1) Antibody (EB5) |
MAB12455-100 |
The Native Antigen Company |
0.1 |
EUR 375.07 |
Description: Recombinant humanised version of the mouse monoclonal antibody MAB12440. Antibody is specific for SARS-CoV-2 spike subunit 1 protein. |
Human IgG1 Anti SARS-CoV-2 Spike (S1) Antibody (EB5) |
MAB12455-500 |
The Native Antigen Company |
0.5 |
EUR 1312.75 |
Description: Recombinant humanised version of the mouse monoclonal antibody MAB12440. Antibody is specific for SARS-CoV-2 spike subunit 1 protein. |
Human IgG1 Anti SARS-CoV-2 Spike (S2) Antibody (CH1) |
MAB12462-100 |
The Native Antigen Company |
0.1 |
EUR 375.07 |
Description: Recombinant humanised version of the mouse monoclonal antibody MAB12447. Antibody is specific for SARS-CoV-2 spike subunit 2 protein. |
Human IgG1 Anti SARS-CoV-2 Spike (S2) Antibody (CH1) |
MAB12462-500 |
The Native Antigen Company |
0.5 |
EUR 1312.75 |
Description: Recombinant humanised version of the mouse monoclonal antibody MAB12447. Antibody is specific for SARS-CoV-2 spike subunit 2 protein. |
Purified anti-mouse IgG1 |
E16SHU501-050U |
EnoGene |
50 μg |
EUR 260 |
Description: Available in various conjugation types. |
Purified anti-mouse IgG1 |
E16SHU501-500U |
EnoGene |
500 μg |
EUR 628.33 |
Description: Available in various conjugation types. |
Mouse Anti-Human IgG1 antibody (Biotin) |
STJ99446-100l |
St John's Laboratory |
100 µl |
EUR 116.4 |
Description: Biotin conjugated Mouse monoclonal to Human IgG1 |
Mouse Anti-Human IgG1 antibody (Biotin) |
STJ99446-1mL |
St John's Laboratory |
1 mL |
EUR 560.4 |
Description: Biotin conjugated Mouse monoclonal to Human IgG1 |
Human IgG1 Anti SARS-CoV-2 Spike (S1) Antibody (HH10) |
MAB12457-100 |
The Native Antigen Company |
0.1 |
EUR 375.07 |
Description: Recombinant humanised version of the mouse monoclonal antibody MAB12442. Antibody is specific for SARS-CoV-2 spike subunit 1 protein. |
Human IgG1 Anti SARS-CoV-2 Spike (S1) Antibody (HH10) |
MAB12457-500 |
The Native Antigen Company |
0.5 |
EUR 1312.75 |
Description: Recombinant humanised version of the mouse monoclonal antibody MAB12442. Antibody is specific for SARS-CoV-2 spike subunit 1 protein. |
Human IgG1 Anti SARS-CoV-2 Spike (S1) Antibody (CR3022) |
MAB12422-100 |
The Native Antigen Company |
0.1 |
EUR 489.89 |
Description: This is a recombinant monoclonal antibody. |
Human IgG1 Anti SARS-CoV-2 Spike (S1) Antibody (CR3022) |
MAB12422-500 |
The Native Antigen Company |
0.5 |
EUR 1865.15 |
Description: This is a recombinant monoclonal antibody. |
Human IgG1 Anti SARS-CoV-2 Spike (S1) Antibody (CR3022) |
MAB12453-100 |
The Native Antigen Company |
0.1 |
EUR 489.89 |
Description: This is a recombinant monoclonal antibody. |
Human IgG1 Anti SARS-CoV-2 Spike (S1) Antibody (CR3022) |
MAB12453-1000 |
The Native Antigen Company |
1.0 |
EUR 3729.02 |
Description: This is a recombinant monoclonal antibody. |
Human IgG1 Anti SARS-CoV-2 Spike (S1) Antibody (CR3022) |
MAB12453-500 |
The Native Antigen Company |
0.5 |
EUR 1865.15 |
Description: This is a recombinant monoclonal antibody. |
Human IgG1, ? Isotype Control Antibody |
A1100-200 |
Biovision |
each |
EUR 933.6 |
Anti-Human IgG1, Rabbit Monoclonal Antibody |
A1801-50 |
Biovision |
each |
EUR 392.4 |
Human IgG1 Anti Dengue Virus NS1 Serotype 1 Antibody (OB4) |
MAB12261-100 |
The Native Antigen Company |
0.1 |
EUR 428.65 |
|
Description: Human IgG1 monoclonal antibody specific for Dengue virus serotype 1 NS1 (clone OB4) |
Human IgG1 Anti Dengue Virus NS1 Serotype 1 Antibody (OB4) |
MAB12261-500 |
The Native Antigen Company |
0.5 |
EUR 1173.69 |
|
Description: Human IgG1 monoclonal antibody specific for Dengue virus serotype 1 NS1 (clone OB4) |
Anti-Human Ephrin Type A receptor 2 (1C1), Human IgG1 Antibody |
A1095-200 |
Biovision |
each |
EUR 874.8 |
PE human IgG1 Kappa |
E16FHCP001K-100U |
EnoGene |
0.1 mg |
EUR 476.67 |
Description: Available in various conjugation types. |
NE human IgG1 Kappa |
E16FHCY001K-500U |
EnoGene |
0.5 mg |
EUR 520 |
Description: Available in various conjugation types. |
Anti-Glycoprotein E (VZV) Antibody, Human IgG1 (4G2) (MALS verified) |
VZV-M545 |
ACROBIOSYSTEMS |
100ug |
EUR 2493.1 |
|
Description: Varicella-zoster virus (VZV) is a neurotropic virus belonging to the Herpesviridae family. Primary VZV infection causes chickenpox and is followed by a life-long latent infection established mainly in the cranial and dorsal root ganglia. Reactivation of the virus is often associated with shingles (herpes zoster). Glycoprotein E (gE) is one of the known glycoproteins (gB, gC, gE, gH, gI, gK, gI) of VZV that is most abundantly expressed on the surface of virus and infected cells, playing an important role in viral replication and cell-to-cell spread. The strongly immunogenic gE can provide strong IgG signal in body fluid, which makes it ideal to be developed as an antigen for analysis of IgG antibodies. gE also demonstrates high potency as a vaccine immunogen and is formulated as the single viral envelope protein that constitutes the GSK VZV recombinant subunit vaccine Shingrix®.The antibody can reacte with gE specially. |
Human IgG1 ELISA KIT |
E42EH-155 |
EnoGene |
96T/48T |
Ask for price |
Anti-Glycoprotein E (VZV) Antibody, Human IgG1 (1B10) (MALS verified) |
VZV-M544 |
ACROBIOSYSTEMS |
100ug |
EUR 2493.1 |
|
Description: Varicella-zoster virus (VZV) is a neurotropic virus belonging to the Herpesviridae family. Primary VZV infection causes chickenpox and is followed by a life-long latent infection established mainly in the cranial and dorsal root ganglia. Reactivation of the virus is often associated with shingles (herpes zoster). Glycoprotein E (gE) is one of the known glycoproteins (gB, gC, gE, gH, gI, gK, gI) of VZV that is most abundantly expressed on the surface of virus and infected cells, playing an important role in viral replication and cell-to-cell spread. The strongly immunogenic gE can provide strong IgG signal in body fluid, which makes it ideal to be developed as an antigen for analysis of IgG antibodies. gE also demonstrates high potency as a vaccine immunogen and is formulated as the single viral envelope protein that constitutes the GSK VZV recombinant subunit vaccine Shingrix®.The antibody can reacte with gE specially. |
Human Immunoglobulin G1 (IgG1) Antibody |
24105-05011 |
AssayPro |
150 ug |
EUR 260.4 |
Human IgG1 Rabbit mAb |
56953 |
SAB |
100ul |
EUR 339 |
Monoclonal Anti-RSV-Pre-F0 specific Antibody, Human IgG1 (12C6) |
RS0-S286 |
ACROBIOSYSTEMS |
1mg |
EUR 374.5 |
|
Description: Human respiratory syncytial virus (HRSV) is the most common etiological agent of acute lower respiratory tract disease in infants and can cause repeated infections throughout life. The RSV fusion glycoprotein (RSV F) is the principal target of RSV neutralizing antibodies in human sera. The RSV F is a type I viral fusion protein synthesized as inactive, single-chain polypeptides that assemble into trimers. RSV F fuses the viral and host cell membranes by irreversible protein refolding from the labile prefusion conformation to the stable post-fusion conformation. |
Human IgG1 Anti SARS-CoV-2 Spike (S1) RBD Antibody (CE5) |
MAB12458-100 |
The Native Antigen Company |
0.1 |
EUR 375.07 |
Description: Recombinant humanised version of the mouse monoclonal antibody MAB12443. Antibody is specific for SARS-CoV-2 receptor binding domain (RBD). |
Human IgG1 Anti SARS-CoV-2 Spike (S1) RBD Antibody (CE5) |
MAB12458-500 |
The Native Antigen Company |
0.5 |
EUR 1312.75 |
Description: Recombinant humanised version of the mouse monoclonal antibody MAB12443. Antibody is specific for SARS-CoV-2 receptor binding domain (RBD). |
Human IgG1 Anti SARS-CoV-2 Spike (S1) RBD Antibody (DH6) |
MAB12459-100 |
The Native Antigen Company |
0.1 |
EUR 375.07 |
Description: Recombinant humanized monoclonal antibody against SARS-CoV-2 receptor binding domain (RBD) protein. Antibody is neutralising against SARS-CoV-2, but not against SARS-CoV-1 or MERS-CoV. |
Human IgG1 Anti SARS-CoV-2 Spike (S1) RBD Antibody (DH6) |
MAB12459-500 |
The Native Antigen Company |
0.5 |
EUR 1312.75 |
Description: Recombinant humanized monoclonal antibody against SARS-CoV-2 receptor binding domain (RBD) protein. Antibody is neutralising against SARS-CoV-2, but not against SARS-CoV-1 or MERS-CoV. |
anti-HSV (I) gD IgG1 |
020-A-01mg |
Virogen |
0,1 mg |
EUR 321 |
|
Description: anti-HSV (I) gD IgG1 (monoclonal) Produced against a HSV (I) viral concentrate |
anti-HSV (I) gD IgG1 |
020-A-1000ug |
Virogen |
1000 ug |
EUR 1539 |
|
Description: anti-HSV (I) gD IgG1 (monoclonal) Produced against a HSV (I) viral concentrate |
Monoclonal Anti-HSV-2-Glycoprotein D Antibody, Human IgG1 (3H9) |
GLD-M609 |
ACROBIOSYSTEMS |
1mg |
EUR 374.5 |
|
Description: Herpesvirus infections are widely spread throughout the world population. Herpes simplex virus (HSV) belongs to the α-herpesvirus subfamily. There are two main types of HSV, HSV-1 and HSV-2, which infect humans. HSV-2 mainly causes genital lesions, whereas HSV-1 is involved in both oral and genital infections. Glycoprotein D (gD) is a structural component of the herpes simplex virus type 1 (HSV-1) envelope which is essential for virus entry and fusion with host cells. gD plays an important role by binding to the host receptors such as herpes virus entry mediator (HVEM) and nectin-1, a member of the immunoglobulin (Ig)-like cell adhesion molecules. |
Monoclonal Anti-HSV-2-Glycoprotein D Antibody, Human IgG1 (8G5) |
GLD-M610 |
ACROBIOSYSTEMS |
1mg |
EUR 374.5 |
|
Description: Herpesvirus infections are widely spread throughout the world population. Herpes simplex virus (HSV) belongs to the α-herpesvirus subfamily. There are two main types of HSV, HSV-1 and HSV-2, which infect humans. HSV-2 mainly causes genital lesions, whereas HSV-1 is involved in both oral and genital infections. Glycoprotein D (gD) is a structural component of the herpes simplex virus type 1 (HSV-1) envelope which is essential for virus entry and fusion with host cells. gD plays an important role by binding to the host receptors such as herpes virus entry mediator (HVEM) and nectin-1, a member of the immunoglobulin (Ig)-like cell adhesion molecules. |
Human IgG1-Fc Protein |
E33P100499 |
EnoGene |
10 μg |
EUR 225 |
Anti HCV Core IGG1 MAB |
216-A-01mg |
Virogen |
0,1 mg |
EUR 321 |
|
Description: anti-HCV core IgG1 (monoclonal)Produced against recombinant antigen |
Anti HCV Core IGG1 MAB |
216-A-1000ug |
Virogen |
1000 ug |
EUR 1539 |
|
Description: anti-HCV core IgG1 (monoclonal)Produced against recombinant antigen |
Goat anti-Dog IgG1 Antibody |
abx401273-1mg |
Abbexa |
1 mg |
EUR 444 |
|
Goat anti-Rat IgG1 Antibody |
abx401431-05mg |
Abbexa |
0.5 mg |
EUR 444 |
|
anti-HCMV gB IgG1 mAb |
024-A-01mg |
Virogen |
0,1 mg |
EUR 321 |
|
Description: anti-HCMV gB IgG1 (monoclonal) Produced against a HCMV infected cells. |
anti-HCMV gB IgG1 mAb |
024-A-1000ug |
Virogen |
1000 ug |
EUR 1539 |
|
Description: anti-HCMV gB IgG1 (monoclonal) Produced against a HCMV infected cells. |
Mouse anti Rat IgG1 (HRP) |
43R-1582 |
Fitzgerald |
100 ug |
EUR 338.4 |
Description: Mouse anti Rat IgG1 antibody (HRP) |
Purified human IgG1 Kappa |
E16FHCU001K-500U |
EnoGene |
0.5 mg |
EUR 433.33 |
Description: Available in various conjugation types. |
Anti-Cortisol antibody *Mouse anti-human, monoclonal IgG1* |
V100220 |
AAT Bioquest |
50 ug |
EUR 367.2 |
|
Anti-Cortisol antibody *Mouse anti-human, monoclonal IgG1* |
V100221 |
AAT Bioquest |
1 mg |
EUR 889.2 |
|
Sheep anti-Cow IgG1 Antibody |
abx401171-1mg |
Abbexa |
1 mg |
EUR 444 |
|
Rat anti-Mouse IgG1 Antibody |
abx401285-1mg |
Abbexa |
1 mg |
EUR 994.8 |
|
Mouse anti-Cow IgG1 Antibody |
abx401338-01mg |
Abbexa |
0.1 mg |
EUR 543.6 |
|
Mouse anti-Cow IgG1 Antibody |
abx401394-01mg |
Abbexa |
0.1 mg |
EUR 610.8 |
|
Mouse anti-Pig IgG1 Antibody |
abx401399-01mg |
Abbexa |
0.1 mg |
EUR 610.8 |
|
anti-HIV-2 gp36 IgG1 |
0114-A-01mg |
Virogen |
0,1 mg |
EUR 321 |
|
Description: anti-HIV-2 gp36 IgG1 (monoclonal) Produced against a recombinant protein. |
anti-HIV-2 gp36 IgG1 |
0114-A-1000ug |
Virogen |
1000 ug |
EUR 1539 |
|
Description: anti-HIV-2 gp36 IgG1 (monoclonal) Produced against a recombinant protein. |
Goat anti Mouse IgG1 (HRP) |
43R-IG060hrp |
Fitzgerald |
1 mg |
EUR 457.2 |
Description: Goat anti Mouse IgG1 secondary antibody (HRP) |
anti-mouse IgG1 mAb, AP |
E409B11-AP100 |
EnoGene |
100μL |
EUR 294 |
Anti-Estradiol antibody *Mouse anti-human, monoclonal IgG1* |
V100185 |
AAT Bioquest |
50 ug |
EUR 367.2 |
|
Breaching the Department of Defense’s Biotech Bottleneck.
The global biotechnology revolution offers a profusion of promising innovations for the US Department of Defense (DoD).
As with other emerging technologies, the commercial market, rather than defense, is driving the evolution of biotechnology products, and the ability to harness biotechnology for defense benefits has been hampered by strategic confusion in DoD. Here we describe a set of high-level challenges and a set of potential solutions that could bring innovative biotechnology closer to reality for the warfighter and DoD writ large.